AbCellera Biologics Inc. ABCL Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s retained earnings?
- AbCellera Biologics Inc. (ABCL) reported retained earnings of -$72.65M in Q1 2026.
- How has AbCellera Biologics Inc.'s retained earnings changed year-over-year?
- AbCellera Biologics Inc.'s retained earnings decreased by 201.9% year-over-year, from $71.31M to -$72.65M.
- What is the long-term trend for AbCellera Biologics Inc.'s retained earnings?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s retained earnings has grown at a -23.7% compound annual growth rate (CAGR), from $114.2M to -$29.48M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.